Month: November 2017

Acquired three products with a combined brand/generic annual market size of $20 million. Filed four new internally created ANDAs with a combined annual marketplace size of $190 million. Received FDA approval for injectable Levofloxacin 25mg/mL single-use vials. Consolidated income for the second one fourth of 2011 was $32.1 million, up 59 percent over the comparable […]

read more

Akorn’s consolidated revenue for fourth quarter 2013 increases 19 percent to $85 million Akorn, Inc. , a niche generic pharmaceutical company, reported financial outcomes for the fourth quarter and year-ended December 31 today, 2013. Raj Rai, CEO commented, ‘2013 was a pivotal calendar year for Akorn http://sildenafilsa.com/kamagra-a-new-competitor-of-viagra-and-cialis.html . As a total result of investment in […]

read more

To clarify the hyperlink between antimicrobial brokers and allergy development, the researchers are organizing a long-term study in babies subjected to antibacterial ingredients at birth, following them throughout childhood. The study was funded by the National Institutes of Wellness training grant amount T32AI007056-31. Co-investigators on the considerable analysis were Elizabeth Matsui, M.D., M.H.S., and Robert […]

read more

Alimera intends to supply that details when it becomes available. Related StoriesTARSA Therapeutics' TBRIA NDA accepted by FDA for reviewMylan announces U.S. Start of generic Fusilev for InjectionMylan announces U.S. Start of generic AXERT tablets In the resubmission, Alimera taken care of immediately questions elevated in the FDA's October 2013 complete response letter and provided […]

read more

Aciphex belongs to band of medicines called proton pump inhibitors – pillsformedicine ACIPHEX that have Rabeprazole is a prescription medicine called a proton pump inhibitor . ACIPHEX decreases the quantity of acid in your abdomen. ACIPHEX can be used in adults: for up to 8 weeks to heal acid-related damage to the lining of the […]

read more

Timothy J. Whelan, B http://cialis-for-sale.org/contact-us .M., B.Ch., Ivo A. Olivotto, M.D., Wendy R. Parulekar, M.D., Ida Ackerman, M.D., Boon H. Chua, M.B., B.S., Ph.D., Abdenour Nabid, M.D., Katherine A. Vallis, M.B., B.S., Ph.D., Julia R. White, M.D., Pierre Rousseau, M.D., Andre Fortin, M.D., Lori J. Pierce, M.D., Lee Manchul, M.D., Susan Chafe, M.D., Maureen C. […]

read more

All recurrent episodes in the antibody group had been in patients who was simply hospitalized throughout their initial episode. The subgroup analysis for hospitalization status was performed post hoc. Inpatients were significantly older and had a considerably higher score on Horn’s index than did outpatients, and there was a development toward more severe infections at […]

read more

‘We are pleased to continue dealing with FastMed as jointly we transform healthcare.’ Houlihan Lokey acted as special financial advisor and McDermott Will & Emery served as legal advisor to FastMed, while Latham & Watkins represented ABRY Partners.. ABRY Partners indications definitive agreement to obtain FastMed Urgent Care ABRY Partners, a leading private equity firm, […]

read more

$3 million grant to aid minorities with uncontrolled diabetes Researchers in the University of Illinois at Chicago’s Institute for Wellness Research and Policy and College of Medicine have obtained a $3 million federal grant to boost diabetes management in minority patients. The grant will fund a five-year research to judge a new intervention designed to […]

read more

Lunch is included. Eat with the doctors and get your questions answered! SO HOW DO I SIGN UP? Call 726-9670 or register on the web at -Launch to Dizziness and the Vestibular Program -What could it be? How does it work? -David Friedland, MD, PhD; Medical University of Wisconsin -Clinical Examination for Dizziness -I'm dizzy […]

read more